Physician, Investor, Venture Builder

---

Dr. Shmouni is a physician-investor with a specialised focus on endocrinology, genomics, and the rapidly advancing field of healthy longevity medicine. He currently serves as a Clinical Assistant Professor of Medicine at the University of British Columbia, where he practices as both an endocrinologist and geneticist. Dr. Hannah-Shmouni's academic credentials include training at the Yale School of Medicine, University of Toronto and the National Institutes of Health (NIH). His expertise in clinical research is particularly centered on disorders related to cortisol and growth hormone, where he has conducted significant investigations into the complex dynamics of hormone secretion and its implications for health across diverse populations. In addition to his clinical and research roles, Dr. Hannah-Shmouni was the founding editor-in-chief of Endocrine and Metabolic Science (Elsevier) and has authored over 100 peer-reviewed manuscripts, reviews, and book chapters, highlighting his commitment to advancing knowledge in his field.

Driven by a commitment to enhancing healthy longevity, Dr. Hannah-Shmouni founded Healthspan Digital, an innovative longevity technology company with headquarters in Toronto, Canada, and Abu Dhabi, UAE. The mission of Healthspan Digital is to advance healthspan services through cutting-edge artificial intelligence software and smart home technologies tailored for the wellness and longevity real estate market. The company's offerings leverage advanced analytics, AI agents, and smart android mirrors to connect businesses and consumers with proactive healthcare management tools, ultimately promoting healthier and longer lives. Healthspan has successfully launched several longevity programs, including initiatives at Lifespan Clinic in Dubai, Astrea Health in Athens, and Supernatural in Toronto.

Dr. Hannah-Shmouni is also actively engaged in the business and investment sectors. As the Managing Partner of FHS Capital, a privately held early-stage investment firm and venture builder, he strategically applies his expertise across various industries, including real estate, precision medicine, wellness, and AI. To date, he has successfully seeded seven innovative companies through FHS Capital, including Healthspan Digital, Geneseq.ai, Staque Life Sciences, Ovenue (acquired by Tinsele), and iWash. Furthermore, he serves as a strategic medical advisor for several venture-backed enterprises, such as Eli Health, AI Nexus Healthcare, Staque.io, Supernatural, and Science & Humans, providing critical insights that leverage his extensive medical knowledge to enhance the success of these pioneering ventures. Dr. Hannah-Shmouni aims to foster meaningful relationships and provide invaluable resources to support innovative businesses and visionary entrepreneurs. He is passionate about empowering individuals and democratizing access to groundbreaking healthcare tools, contributing to the evolution of healthcare and enhancing the well-being of communities globally.